论文部分内容阅读
目的 临床观察抗血管内皮生长因子(vascular endothelial growth factor,VEGF)(雷珠单抗注射液,Ranibizumab)治疗脉络膜新生血管(choroidal neurovascularization,CNV)眼底病的非年龄相关性黄斑变性(age-related macular degeneration,AMD)患者的疗效。